}

FDA orders updated warnings for fluoroquinolones

07/16/2018

The FDA is requiring safety labeling changes for fluoroquinolones to strengthen the warnings about the risks of mental health side effects and serious blood sugar disturbances in this class of antibiotics. The new requirement will also make these warnings more consistent across the labeling for all fluoroquinolones taken by mouth or given by injection.

<< return to Advocacy Updates